In weight loss circles, it is often described as fat loss focused with less emphasis on blood sugar effects
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (under the brand name Mounjaro), chronic weight management (under the brand name Zepbound), and most recently in 2024, for the treatment of adults with moderate-to-severe obstructive sleep apnea who have obesity or are overweight with at least one weight-related comorbidity
If you think youll have trouble remembering the injection sites from week to week, you could always place a small Band-Aid over the injection site as a visual reminder for the following week
Box Contents 6 Pads
Brand-name drugs are subject to pharmaceutical company pricing, which can be significantly higher due to research, development, and marketing costs and corporate profitability
Nausea typically lessens within 1 to 2 weeks as your body adjusts to tirzepatide